NCT00353106

Brief Summary

Primary Objectives:

  1. 1.To explore the experience of chronic graft-versus-host disease (cGVHD) following allogeneic blood or marrow transplantation from the perspective of the patient and the patient's primary family caregiver.
  2. 2.To develop and validate an instrument to measure the severity of multiple symptoms and the impact of these symptoms on daily functioning in patients who have cGVHD.
  3. 3.To develop a detailed description of the experience of having cGVHD.
  4. 4.To develop a detailed description of the symptom experience of cGVHD to allow for development of a symptoms instrument for cGVHD.
  5. 5.To assess the understanding of questions to measure the symptoms of cGVHD in patients with various levels of education.
  6. 6.To develop a detailed description of caring for a patient with cGVHD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
187

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2006

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2006

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 13, 2006

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 17, 2006

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2010

Completed
Last Updated

July 30, 2012

Status Verified

July 1, 2012

Enrollment Period

3.9 years

First QC Date

July 13, 2006

Last Update Submit

July 27, 2012

Conditions

Keywords

Graft-Versus-Host DiseaseGVHDChronic Graft-Versus-Host DiseasecGVHDInterviewQuestionnaireSurveyCaregiver

Outcome Measures

Primary Outcomes (1)

  • Phase 1: Open-Ended Interview/Questions designed to elicit specific descriptions of experience of having cGVHD or caring for a patient with cGVHD

    At time of treatment, duration approximately 30 minutes

Study Arms (3)

Patients

Patients with chronic GVHD

Behavioral: InterviewBehavioral: Questionnaire

Content Expert Panel

Content expert panel with 5 years experience caring for patients with cGVHD.

Behavioral: Questionnaire

Caregivers

Caregivers of patients with cGVHD

Behavioral: InterviewBehavioral: Questionnaire

Interventions

InterviewBEHAVIORAL

30-minute interviews of participating patients and their caregiver(s).

CaregiversPatients
QuestionnaireBEHAVIORAL

Questionnaires that will take approximately 5 minutes to complete.

Also known as: Survey
CaregiversContent Expert PanelPatients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Study participants with chronic graft-versus-host disease (cGVHD) following allogeneic blood or marrow transplantation, the patient's primary family caregiver, and content expert panel.

You may qualify if:

  • years of age or older
  • Ability to speak and read English
  • Clinical or histological diagnosis of active cGVHD or at least 3 months post allogeneic BMT without a diagnosis of active GVHD (PATIENT ONLY)
  • Identification as the single primary family caregiver by a patient with cGVHD (CAREGIVER ONLY)
  • Physician or nurse with at least 5 years experience caring for patients with cGHVD (PROFESSIONAL EXPERT ONLY)
  • At least one publication in the last 5 years dealing with cGVHD (PHYSICIAN PROFESSIONAL EXPERT ONLY)
  • Consent to participate

You may not qualify if:

  • Inability to understand the intent of the study
  • Medical condition that would preclude participation in an interview lasting 30 minutes (PHASE 1 OF STUDY ONLY)
  • Diagnosis of active psychosis or severe cognitive impairment
  • Bone marrow or stem cell donor for patient (CAREGIVER ONLY)
  • Disease for which BMT was performed not in remission (PATIENT ONLY)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Roswell Park Cancer Institute

Buffalo, New York, 14263, United States

Location

UT MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Conditions

Graft vs Host DiseaseBronchiolitis Obliterans Syndrome

Interventions

Interviews as TopicSurveys and Questionnaires

Condition Hierarchy (Ancestors)

Immune System DiseasesOrganizing PneumoniaBronchiolitis ObliteransBronchiolitisBronchitisBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Loretta A. Williams, DSN

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 13, 2006

First Posted

July 17, 2006

Study Start

February 1, 2006

Primary Completion

January 1, 2010

Study Completion

January 1, 2010

Last Updated

July 30, 2012

Record last verified: 2012-07

Locations